Back

Avience Biomedicals Ltd

IPO Details · GMP · Subscription · Financials

✅ Listed NSE SME SME Live Chart
Issue Price
₹208
Per Share
GMP
+₹75
+36.06% Grey Market
Est. Listing
₹283
Expected Price
Min. Application
₹249,600
2 lots × 600 shares
IPO Issue Details
Issue Price / Price Band₹208 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size600 Shares per Lot
Total Issue Size14,53,800 shares (agg. up to ₹30 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh capital only
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenThu, 18 Jun 2026
Subscription CloseMon, 22 Jun 2026
Anchor AllotmentWed, 17 Jun 2026
Basis of AllotmentTue, 23 Jun 2026
Initiation of RefundsWed, 24 Jun 2026
Credit of Shares to DematWed, 24 Jun 2026
Listing DateThu, 25 Jun 2026
UPI Mandate Deadline5:00 PM on 22 Jun 2026 (Day 3)
Application & Investment Details
Retail — Min (2 Lots)₹2,49,600 — 1,200 shares
Retail — Max (13 Lots)₹1,622,400 (13 Lots)
HNI — Min (3 Lots)₹3,74,400 — 1,800 shares
EPS (Pre-IPO)₹17.94
EPS (Post-IPO)₹12.56
P/E Ratio (Pre-IPO)11.59x
P/E Ratio (Post-IPO)16.56x
Net Offer to Public13,71,600 shares (agg. up to ₹29 Cr)
Reserved for Market Maker82,200 shares (agg. up to ₹2 Cr)
Pre-IPO Promoter Holding40,31,256 shares
Post-IPO Promoter Holding54,85,056 shares
Fresh Issue Shares13,71,600 shares (agg. up to ₹29 Cr)
About Avience Biomedicals Ltd

Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets.The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas.In addition to manufacturing, the Company also act as distributors and traders of medical equipment.The company's manufacturing unit is situated in Noida, Uttar Pradesh.The company offers a comprehensive range of diagnostic solutions, including:Rapid Test Kits: Products like AVISURE Dengue Combo Test, Malaria Rapid Test (Pf/Pv), and AVISURE Syphilis Rapid Test.Biochemistry Analyzers and Reagents: Devices like the BS-240 Fully Auto Analyzer and reagents like AVIENBIO Albumin Kit.Molecular Diagnostics: COVID-19 detection kits, including the COVID-19 Hid RTqPCR ASSAY.Hematology Analyzers: Models like the BC-20s 3-Part Hematology Analyzer.Medical Devices: Oxygen concentrators (Oxy-5 and Oxy-10) and viral transport solutions (VTM).As of January 31, 2026, the company had 75 permanent employees and 33 contractual employeesCompetitive StrengthStrong Industry Experience and Expertise.Avience provides various diagnostic products, including rapid test kits, analyzers, hematology devices, and molecular kits.Strong distribution network across India and is growing its international footprint.Cost-Effective and Affordable Solutions.Stringent quality control processes and complies with ISO standards and regulatory approvals.

Objects of the Issue

Avience Biomedicals Ltd proposes to utilise the net proceeds from the Issue for the following objects:

1
Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
15.96
2
Funding the working capital requirements of the Company
8.25
3
General Corporate Purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding 40,31,256 shares
Post-IPO Promoter Holding 54,85,056 shares
Check AllotmentCheck Status →
Avience Biomedicals Ltd — Live Price LIVE
₹208.00
INR · NSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Avience Biomedicals Ltd is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹208.00 GMP: +₹75 (+36.06%) Live Price
Quick Facts
GMP Signal🟢 Positive
StatusListed
Issue Price₹208
GMP+₹75
Est. Listing₹283
Lot Size600 shares
Min Amount₹249,600
Listing Date25 Jun 2026
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹208
Listing Date25 Jun 2026
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
QIB (Ex Anchor) 683,400 ₹14.21 Cr 78.80x
NII / HNI 207,000 ₹4.31 Cr 597.72x
Retail (RII) 481,200 ₹10.01 Cr 394.72x
Market Maker 82,200 ₹1.71 Cr
TOTAL 1,371,600 100.00% ₹28.53 Cr 267.95x
* Based on ₹208.00 (upper price band)
Day-wise Subscription
QIB
78.80x
NII / HNI
597.72x
Retail
394.72x
Total
267.95x
Subscribed
Lot Size & Investment Details
Lot Size
600
Shares
Issue Price
₹208.00
Per Share
Min Investment
₹124,800
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 600 ₹124,800
Retail (Max) 13 7,800 ₹1,622,400
sNII (Min) 14 8,400 ₹1,747,200
bNII (Min) 68 40,800 ₹8,486,400
Company Financials — Restated Consolidated (Amount in ₹ Crore)
Particulars31 Mar 202531 Mar 202431 Mar 2023
Revenue from Operations 29.54 16.64 10.93
EBITDA 7.65 3.15 1.43
Profit After Tax (PAT) 5.19 1.99 0.78
Net Worth 20.60 6.07 4.08
Total Assets 43.60 25.63 10.02
Reserves & Surplus 16.57 2.79 0.79
Total Borrowings 13.75 7.73 2.66
Key Ratios & Valuation
Issue Price ₹208
Face Value ₹10 Per Share
P/BV 2.94
RoE 22.38
RoCE 16.99
RoNW 22.38
PAT Margin (%) 15.86
EBITDA Margin (%) 24.70
Debt / Equity 0.94
Company Details
Company
Avience Biomedicals Ltd
Exchange
NSE SME
IPO Type
SME IPO
Issue Type
Bookbuilding IPO
Face Value
₹10 Per Share
Script Code
N/A
Address
C-11, Block-C Community Centre, Janakpuri A-3, Delhi, New Delhi, 110058
Book Running Lead Managers
Fintellectual Corporate Advisors Pvt.Ltd
Book Running Lead Manager (BRLM)